| I'm in my 40s with genetic predisposition for Alzheimer's. Been seriously considering the past year or two paying out of pocket for Shingrix. I think it would be ~$500 total for two doses. Sure, I could wait 7 or 8 years until I qualify via insurance, but is that really worth the risk for what is an easily absorbed cost to me? Especially when I have a friend in her late 30s who just went through a very rough bout of shingles? It makes sense to have targets like age 50 for population-wide public health recommendations. But it can and does infect people of much earlier ages. Recent articles like this make me think I'll go ahead. |
https://youtu.be/qlTnnQytOJ0?is=XJ0c5pWVV6Lg0IMs
As per one of the slides around 7 minutes in, there are many vaccines that show a 20-40% reduction in mortality and dementia.
The talk above basically says that “observational studies” may show great results, like the so-called protective action of the shingles vaccine against dementia. However when brought to a well designed RCT all those benefits don’t actually show up. And the speaker shows later on that the shingles vaccines shows a marked benefit for shingles but nothing for dementia.